Related Experiment Video
Updated: May 20, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Enamino-oxindole HIV protease inhibitors
Michael Eissenstat1, Tanya Guerassina, Sergei Gulnik
1Sequoia Pharmaceuticals, Inc., Gaithersburg, MD 10878, USA. eissenst@comcast.net
Abstract:
We have designed and synthesized a series of HIV protease inhibitors (PIs) with enamino-oxindole substituents optimized to interact with the S2' subsite of the HIV protease binding pocket. Several of these inhibitors have sub-nanomolar K(i) and antiviral IC(50) in the low nM range against WT HIV and against a panel of multi-drug resistant (MDR) strains.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Types of Enols and Enolates
Enzyme Inhibition
Aldehydes and Ketones with Amines: Imine and Enamine Formation Overview
Dipeptidyl Peptidase 4 Inhibitors
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...

